| Title |
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
|
|---|---|
| Published in |
Clinical Cancer Research, August 2019
|
| DOI | 10.1158/1078-0432.ccr-19-0624 |
| Pubmed ID | |
| Authors |
Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona-Calero, Daniel Dix, Justin I. Odegaard, Richard B. Lanman, Vassiliki A. Papadimitrakopoulou |
X Demographics
The data shown below were collected from the profiles of 75 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 19 | 25% |
| Spain | 11 | 15% |
| France | 5 | 7% |
| Canada | 5 | 7% |
| Brazil | 1 | 1% |
| Indonesia | 1 | 1% |
| Greece | 1 | 1% |
| Turkey | 1 | 1% |
| Japan | 1 | 1% |
| Other | 3 | 4% |
| Unknown | 27 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 47 | 63% |
| Scientists | 22 | 29% |
| Practitioners (doctors, other healthcare professionals) | 5 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 267 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 267 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 39 | 15% |
| Student > Ph. D. Student | 29 | 11% |
| Other | 23 | 9% |
| Student > Postgraduate | 20 | 7% |
| Student > Master | 17 | 6% |
| Other | 43 | 16% |
| Unknown | 96 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 72 | 27% |
| Biochemistry, Genetics and Molecular Biology | 47 | 18% |
| Agricultural and Biological Sciences | 11 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 2% |
| Immunology and Microbiology | 5 | 2% |
| Other | 14 | 5% |
| Unknown | 113 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 273. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 August 2023.
All research outputs
#133,598
of 25,713,737 outputs
Outputs from Clinical Cancer Research
#54
of 13,295 outputs
Outputs of similar age
#2,452
of 360,489 outputs
Outputs of similar age from Clinical Cancer Research
#2
of 200 outputs
Altmetric has tracked 25,713,737 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,295 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,489 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 200 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.